Respiratory virus season looms, officials warn
The arrival of cooler weather and people gathering indoors can lead to the increased spread of COVID-19, influenza and respiratory syncytial virus (or RSV), officials said Thursday. Oregon hospitals were overwhelmed in 2022 from a surge of RSV cases coupled with rises in COVID-19 and influenza.
Respiratory syncytial virus vaccination in older adults
Most people experience mild RSV reinfections throughout their lifetime, particularly during respiratory virus season (November to March in Canada). People are at higher risk if they are older than 75 years or if they have comorbid conditions (e.
Health officials recommend Stanislaus County residents get respiratory virus vaccinations
We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for California.
‘Risk Less. Do More.’: Health experts across Oregon urge vaccinations as respiratory virus season begins
As the 2024-2025 respiratory virus season gets under way, statewide infectious disease experts urge everyone in Oregon to Risk Less. Do More. in alignment with a U.S. Department of Health and Human Services national vaccination campaign.
Oregon faces measles, pertussis outbreaks ahead of respiratory virus season
Oregonians urged to get vaccinated for respiratory virus season
The Oregon Health Authority and public health officials said a winter, fall surge of COVID-19 and the flu are likely.
Vaccination is critical ahead of unpredictable respiratory virus season, Oregon health officials warn
The Lancet13d
Respiratory Syncytial Virus
(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...
Respiratory infection vaccine to be rolled out
A vaccine to protect babies and older adults against a common but potentially dangerous respiratory infection is set to be ...
CMAJ13d
Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost–utility analysis
Background: Respiratory syncytial virus (RSV) vaccines could reduce disease burden and costs in older Canadian adults, but vaccination program cost-effectiveness is unknown. We evaluated the ...
Global Respiratory Syncytial Virus Market Was Valued At US$ 2,331.3 Million In 2023 Astute Analytica
CHICAGO, CA, UNITED STATES, September 16, 2024 /EINPresswire / -- The global respiratory syncytial virus (RSV) <a target=_blank href=htt ...
Taiwan News5d
Respiratory Syncytial Virus Therapeutics Market Analysis, Trends, Innovations, and Forecast (2024-2032)
Global Respiratory Syncytial Virus Therapeutics Market was valued at approximately USD 5.88 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.82% over the forecast ...
Yahoo Finance4d
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co ...